Author

Go Urabe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:rat· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Bowen WangiD· 2 shared Lian-Wang Guo· 2 shared Mengxue Zhang· 2 shared Yitao HuangiD· 2 shared Allyson Huttinger· 1 shared David Dornbos· 1 shared Debra Wheeler· 1 shared Guojun Chen· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Bowen WangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintMar 31, 2019

A non-canonical role and regulations of polo-like kinase-4 in fibroblast cell-type transition

Jing Li, Go Urabe, Mengxue Zhang…·Lian-Wang Guo

This study identifies a non-canonical role for PLK4 in fibroblast cell-type transition and shows its regulation by BRD4 and PDGFR pathways, suggesting PLK4 inhibition as a potential anti-fibrotic intervention.

DOI 10.1101/570267

ratexperimental assay

𝕏 PostBluesky

PathologybioRxivPreprintMar 18, 2019

PERK inhibition mitigates restenosis and thrombosis - a potential low-thrombogenic anti-restenotic paradigm

Bowen Wang, Mengxue Zhang, Go Urabe…·K Craig Kent

This study shows that PERK inhibition reduces restenosis and thrombosis in animal models, suggesting it as a potential therapeutic strategy for drug-eluting stents.

DOI 10.1101/581397

ratmouse

𝕏 PostBluesky